Jin Ooi > Kirkland & Ellis International LLP > London, England > Lawyer Profile

Praised for its ‘unbeatable combination of experience, talent and tenacity’, Kirkland & Ellis International LLP operates for a consortium of notable clients in multi-faceted mandates that tackle complex issues such as SEP/FRAND and technically challenging M&A. Nicola Dagg helms the litigation side of the practice with her market traction in the most cutting-edge mandates, while Emma Flett, who leads the technology and transactional side of the practice, demonstrates a strong grounding in a litany of mandates, from private equity transactions and M&A to licensing and development issues. Daniel Lim is well positioned to represent clients in litigation that involves medical devices, SEP/FRAND, and blockbusters in the life sciences space. Steven Baldwin is notably active in the High Court, representing clients in relation to high-tech and life sciences issues. Another name to note is experienced litigator Jin Ooi, who is pre-eminent in the fields of life sciences and consumer products. Katie Coltart departed to Linklaters LLP in September 2023.

Described as ‘one of the best teams in life sciences and healthcare in London’ Kirkland & Ellis International LLP advises a multitude of major life sciences companies on the global formulation and coordination of life science patent litigation strategy. Daniel Lim co-heads the practice and has a proven track record in pharmaceutical and medical device litigation. Fellow co-head Nicola Dagg is a known name for work including strategic patent and product lifecycle advice. Emma Flett completes the leadership team and is geared to advise on the of IP aspects of M&A transactions. SPC disputes relating to biologic and small molecule products are a practice strength of Steven Baldwin, while Jin Ooi works extensively on follow-on damages inquiry mandates.